Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Retinal thinning differentiates treatment effects in relapsing multiple sclerosis below the clinical threshold.
Bsteh G, Hegen H, Krajnc N, Föttinger F, Altmann P, Auer M, Berek K, Kornek B, Leutmezer F, Macher S, Monschein T, Ponleitner M, Rommer P, Schmied C, Zebenholzer K, Zulehner G, Zrzavy T, Deisenhammer F, Di Pauli F, Pemp B, Berger T. Bsteh G, et al. Among authors: kornek b. Ann Clin Transl Neurol. 2024 Dec 16. doi: 10.1002/acn3.52279. Online ahead of print. Ann Clin Transl Neurol. 2024. PMID: 39686570 Free article.
Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC score.
Bsteh G, Hegen H, Riedl K, Altmann P, Auer M, Berek K, Di Pauli F, Ehling R, Kornek B, Monschein T, Rinner W, Schmied C, Wurth S, Zebenholzer K, Zinganell A, Zrzavy T, Zulehner G, Deisenhammer F, Rommer P, Leutmezer F, Berger T. Bsteh G, et al. Among authors: kornek b. Eur J Neurol. 2021 May;28(5):1609-1616. doi: 10.1111/ene.14705. Epub 2021 Jan 18. Eur J Neurol. 2021. PMID: 33370478 Free PMC article.
Retinal Layer Thinning After Optic Neuritis Is Associated With Future Relapse Remission in Relapsing Multiple Sclerosis.
Bsteh G, Krajnc N, Riedl K, Altmann P, Kornek B, Leutmezer F, Macher S, Mitsch C, Pruckner P, Rommer PS, Zulehner G, Pemp B, Berger T; Vienna Multiple Sclerosis Database Study Group. Bsteh G, et al. Among authors: kornek b. Neurology. 2022 Oct 18;99(16):e1803-e1812. doi: 10.1212/WNL.0000000000200970. Epub 2022 Aug 2. Neurology. 2022. PMID: 35918172 Free PMC article.
Retinal layer thickness predicts disability accumulation in early relapsing multiple sclerosis.
Bsteh G, Hegen H, Altmann P, Auer M, Berek K, Di Pauli F, Haider L, Kornek B, Krajnc N, Leutmezer F, Macher S, Rommer P, Walchhofer LM, Zebenholzer K, Zulehner G, Deisenhammer F, Pemp B, Berger T. Bsteh G, et al. Among authors: kornek b. Eur J Neurol. 2023 Apr;30(4):1025-1034. doi: 10.1111/ene.15718. Epub 2023 Feb 16. Eur J Neurol. 2023. PMID: 36719184
Retinal layer thinning for monitoring disease-modifying treatment in relapsing multiple sclerosis-Evidence for applying a rebaselining concept.
Bsteh G, Hegen H, Krajnc N, Föttinger F, Altmann P, Auer M, Berek K, Kornek B, Leutmezer F, Macher S, Monschein T, Ponleitner M, Rommer P, Schmied C, Zebenholzer K, Zulehner G, Zrzavy T, Deisenhammer F, Di Pauli F, Pemp B, Berger T. Bsteh G, et al. Among authors: kornek b. Mult Scler. 2024 Aug;30(9):1128-1138. doi: 10.1177/13524585241267257. Epub 2024 Aug 7. Mult Scler. 2024. PMID: 39109593 Free article.
Association of Disease-Modifying Treatment With Outcome in Patients With Relapsing Multiple Sclerosis and Isolated MRI Activity.
Bsteh G, Aicher ML, Walde JF, Krajnc N, Haider L, Traxler G, Gradl C, Salmen A, Riedl K, Poskaite P, Leyendecker P, Altmann P, Auer M, Berek K, Di Pauli F, Kornek B, Leutmezer F, Rommer PS, Zulehner G, Zrzavy T, Deisenhammer F, Chan A, Berger T, Hoepner R, Hammer H, Hegen H. Bsteh G, et al. Among authors: kornek b. Neurology. 2024 Sep 24;103(6):e209752. doi: 10.1212/WNL.0000000000209752. Epub 2024 Aug 28. Neurology. 2024. PMID: 39197111
Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR).
Monschein T, Dekany S, Zrzavy T, Ponleitner M, Altmann P, Bsteh G, Kornek B, Rommer P, Enzinger C, Di Pauli F, Kraus J, Berger T, Leutmezer F, Guger M; Austrian MS Treatment Registry (AMSTR). Monschein T, et al. Among authors: kornek b. J Neurol. 2023 Aug;270(8):3779-3786. doi: 10.1007/s00415-023-11686-2. Epub 2023 Apr 19. J Neurol. 2023. PMID: 37074388 Free PMC article.
73 results